We have previously demonstrated the feasibility of such a concomitant multi-targeting approach using an artificial protein encompassing limited MS/EAE-related epitopes of MBP, PLP, and MOG, as a multi-epitope targeting agent [33]. This evidence concerns the gene MOG and myeloid sarcoma.